DEA Clears One Hurdle to “Meaningful Use” of EHR

Wed, Apr 14, 2010

Breaking News

E-Prescribing of Controlled Substances Allowed Under New Regs

Doing its part to hasten the EHR revolution, the Drug Enforcement Administration issued an interim final rule on March 31, 2010 revising its regs to allow pharmacies, hospitals and physicians to use electronic prescriptions for controlled substances, known as Schedule II drugs, such as opioids, stimulants, depressants, hallucinogens, and anabolic steroids.

This opens a door for practitioners to prove they are “meaningful EHR users” under the ARRA and HITECH and thus be eligible for incentive payments beginning next year. The DEA’s new regs align federal policies on controlled substances with the goal of moving the health care industry toward e-prescribing.

The new regs’ goal is to maintain a “closed system of controls on controlled substances dispensing,” says the DEA. Other benefits include reduction of paperwork for DEA registrants who dispense controlled substances, cutting down on prescription forgery, reducing errors…

Click here to login and get access to this article if you already receive the HIT News Wire
If you've already signed in and are still seeing this screen, click here to refresh the page.
HIT News Wire
Free registration required for full access to articles.
You will also receive
  • Free updates on the latest developments affecting healthcare IT.
  • Discounts on 3rd party offers.
Join now
You must have javascript enabled to use this form
Bookmark and Share
, , , ,